IN2014DN08483A - - Google Patents
Info
- Publication number
- IN2014DN08483A IN2014DN08483A IN8483DEN2014A IN2014DN08483A IN 2014DN08483 A IN2014DN08483 A IN 2014DN08483A IN 8483DEN2014 A IN8483DEN2014 A IN 8483DEN2014A IN 2014DN08483 A IN2014DN08483 A IN 2014DN08483A
- Authority
- IN
- India
- Prior art keywords
- leu
- subjected
- val
- linear
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to processes and intermediates useful for the manufacture of cyclic undecapeptides such as Alisporivir a non immunosuppressive cyclosporine A derivative. The cyclosporin is acylated on the butenyl methyl threonine side chain and then subjected to a ring opening reaction (the ring opens between the sarcosine and the N methyl leucine residues). This linear peptide intermediate is subjected to Edman degradation (removal of the N terminal residue) as to give the second linear decapeptide intermediate e.g. of sequence Val N(Me)Leu Ala Ala N(Me)Leu N(Me) Leu N(Me)Val N(Me)Bmt Abu Sar when starting from CsA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261644616P | 2012-05-09 | 2012-05-09 | |
| PCT/EP2013/059672 WO2013167703A1 (en) | 2012-05-09 | 2013-05-08 | Process for the manufacture of cyclic undecapeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08483A true IN2014DN08483A (en) | 2015-05-08 |
Family
ID=48444372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8483DEN2014 IN2014DN08483A (en) | 2012-05-09 | 2013-05-08 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20150087808A1 (en) |
| EP (1) | EP2847211A1 (en) |
| JP (3) | JP2015517481A (en) |
| KR (1) | KR20150006435A (en) |
| CN (2) | CN104284902A (en) |
| AR (1) | AR090964A1 (en) |
| AU (2) | AU2013257989A1 (en) |
| BR (1) | BR112014027648A2 (en) |
| CA (1) | CA2868940A1 (en) |
| CL (1) | CL2014003014A1 (en) |
| CO (1) | CO7141428A2 (en) |
| EA (1) | EA024903B1 (en) |
| EC (1) | ECSP14030537A (en) |
| HK (1) | HK1202555A1 (en) |
| IL (1) | IL235428A0 (en) |
| IN (1) | IN2014DN08483A (en) |
| MA (1) | MA20150231A1 (en) |
| MX (1) | MX2014013613A (en) |
| PE (1) | PE20142433A1 (en) |
| PH (1) | PH12014502499A1 (en) |
| SG (1) | SG11201406303XA (en) |
| TN (1) | TN2014000411A1 (en) |
| TW (1) | TW201350508A (en) |
| WO (1) | WO2013167703A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105693820A (en) * | 2014-11-27 | 2016-06-22 | 武汉药明康德新药开发有限公司 | Degradation method of cyclosporine A |
| EP3623378A4 (en) | 2017-05-12 | 2021-03-03 | Chugai Seiyaku Kabushiki Kaisha | Method for producing cyclic organic compound |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT401177B (en) | 1993-10-22 | 1996-07-25 | Biochemie Gmbh | PROCESS FOR THE PREPARATION OF 7-AMINO-3-CEPHEM-4-CARBONIC ACID DERIVATIVES |
| ATE312843T1 (en) * | 1998-07-01 | 2005-12-15 | Debiopharm Sa | NEW CYCLOSPORIN WITH IMPROVED EFFECTS |
| ATE330968T1 (en) * | 1999-02-05 | 2006-07-15 | Debiopharm Sa | CYCLOSPORINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
| RU2290196C2 (en) * | 2001-04-20 | 2006-12-27 | Дебиофарм С.А. | Modified cyclosporin that can be used as prodrug and its using |
| WO2003033526A2 (en) * | 2001-10-19 | 2003-04-24 | Isotechnika Inc. | Synthesis of cyclosporin analogs |
| TW200505946A (en) | 2003-04-08 | 2005-02-16 | Hoffmann La Roche | Process for preparation of cyclosporin a analog |
| ES2357587T3 (en) | 2004-10-01 | 2011-04-27 | Debiopharm S.A. | USE OF (D-MEALA) 3- (ETVAL) 4-CYCLOSPORINE FOR THE TREATMENT OF INFECTION WITH HEPATITIS C. |
| US20060223743A1 (en) * | 2004-12-17 | 2006-10-05 | Mark Abel | Metabolites of cyclosporin analogs |
| EP2124992A2 (en) | 2007-01-04 | 2009-12-02 | Debiopharm S.A. | Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| EP2195009B1 (en) | 2007-09-26 | 2014-07-30 | Oregon Health and Science University | Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
| US7910378B2 (en) * | 2007-12-14 | 2011-03-22 | Siemens Healthcare Diagnostics Inc. | Methods for detection of hydrophobic drugs |
| WO2009098533A1 (en) | 2008-02-08 | 2009-08-13 | Debiopharm Sa | Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| JP5758806B2 (en) | 2008-11-06 | 2015-08-05 | デビオ ルシェルシュ ファルマスーティク ソシエテ アノニムＤｅｂｉｏ Ｒｅｃｈｅｒｃｈｅ Ｐｈａｒｍａｃｅｕｔｉｑｕｅ Ｓｏｃｉｅｔｅ Ａｎｏｎｙｍｅ | Cycloundecadepsipeptide compound and use of the compound as a medicament |
| CA2748389A1 (en) * | 2008-12-31 | 2010-07-08 | Scynexis, Inc. | Derivatives of cyclosporin a |
| EP2391376A4 (en) * | 2009-01-30 | 2012-08-01 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c infection |
| WO2012021796A2 (en) * | 2010-08-12 | 2012-02-16 | S&T Global, Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
-
2013
- 2013-05-07 AR ARP130101557A patent/AR090964A1/en unknown
- 2013-05-08 CA CA2868940A patent/CA2868940A1/en not_active Abandoned
- 2013-05-08 PE PE2014001983A patent/PE20142433A1/en not_active Application Discontinuation
- 2013-05-08 EP EP13722740.1A patent/EP2847211A1/en not_active Withdrawn
- 2013-05-08 CN CN201380023760.8A patent/CN104284902A/en active Pending
- 2013-05-08 IN IN8483DEN2014 patent/IN2014DN08483A/en unknown
- 2013-05-08 US US14/399,261 patent/US20150087808A1/en not_active Abandoned
- 2013-05-08 CN CN201810575515.2A patent/CN108715606A/en active Pending
- 2013-05-08 EA EA201492036A patent/EA024903B1/en not_active IP Right Cessation
- 2013-05-08 TW TW102116414A patent/TW201350508A/en unknown
- 2013-05-08 JP JP2015510823A patent/JP2015517481A/en not_active Withdrawn
- 2013-05-08 KR KR1020147031112A patent/KR20150006435A/en not_active Application Discontinuation
- 2013-05-08 AU AU2013257989A patent/AU2013257989A1/en not_active Abandoned
- 2013-05-08 SG SG11201406303XA patent/SG11201406303XA/en unknown
- 2013-05-08 MA MA37498A patent/MA20150231A1/en unknown
- 2013-05-08 MX MX2014013613A patent/MX2014013613A/en unknown
- 2013-05-08 BR BR112014027648A patent/BR112014027648A2/en not_active IP Right Cessation
- 2013-05-08 WO PCT/EP2013/059672 patent/WO2013167703A1/en active Application Filing
-
2014
- 2014-09-30 TN TNP2014000411A patent/TN2014000411A1/en unknown
- 2014-10-30 IL IL235428A patent/IL235428A0/en unknown
- 2014-11-07 CL CL2014003014A patent/CL2014003014A1/en unknown
- 2014-11-10 CO CO14248207A patent/CO7141428A2/en unknown
- 2014-11-10 PH PH12014502499A patent/PH12014502499A1/en unknown
- 2014-12-08 EC ECIEPI201430537A patent/ECSP14030537A/en unknown
-
2015
- 2015-03-20 HK HK15102858.0A patent/HK1202555A1/en unknown
-
2016
- 2016-06-30 US US15/198,152 patent/US9840534B2/en not_active Expired - Fee Related
- 2016-08-31 AU AU2016222370A patent/AU2016222370B2/en not_active Ceased
-
2017
- 2017-08-29 JP JP2017164867A patent/JP2018035154A/en not_active Withdrawn
-
2019
- 2019-09-30 JP JP2019179311A patent/JP2020033349A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016222370A1 (en) | 2016-09-15 |
| PE20142433A1 (en) | 2015-02-02 |
| WO2013167703A1 (en) | 2013-11-14 |
| JP2018035154A (en) | 2018-03-08 |
| IL235428A0 (en) | 2014-12-31 |
| CO7141428A2 (en) | 2014-12-12 |
| WO2013167703A9 (en) | 2014-11-20 |
| BR112014027648A2 (en) | 2017-06-27 |
| TW201350508A (en) | 2013-12-16 |
| KR20150006435A (en) | 2015-01-16 |
| ECSP14030537A (en) | 2015-09-30 |
| CN104284902A (en) | 2015-01-14 |
| TN2014000411A1 (en) | 2015-12-21 |
| US9840534B2 (en) | 2017-12-12 |
| JP2015517481A (en) | 2015-06-22 |
| MX2014013613A (en) | 2015-02-12 |
| AU2013257989A1 (en) | 2014-10-23 |
| SG11201406303XA (en) | 2014-11-27 |
| CA2868940A1 (en) | 2013-11-14 |
| US20160304554A1 (en) | 2016-10-20 |
| AR090964A1 (en) | 2014-12-17 |
| CL2014003014A1 (en) | 2015-03-06 |
| EA024903B1 (en) | 2016-10-31 |
| EA201492036A1 (en) | 2015-02-27 |
| CN108715606A (en) | 2018-10-30 |
| EP2847211A1 (en) | 2015-03-18 |
| JP2020033349A (en) | 2020-03-05 |
| PH12014502499A1 (en) | 2014-12-22 |
| MA20150231A1 (en) | 2015-07-31 |
| US20150087808A1 (en) | 2015-03-26 |
| AU2016222370B2 (en) | 2017-10-05 |
| HK1202555A1 (en) | 2015-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102112373B1 (en) | Peptidomimetic macrocycles | |
| IN2014DN08483A (en) | ||
| HRP20120621T1 (en) | Potent compstatin analogs | |
| MX364911B (en) | Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role. | |
| NZ724904A (en) | Hybrid immunoglobulin containing non-peptidyl linkage | |
| NZ594302A (en) | Beta-arrestin effectors and compositions and methods of use thereof | |
| WO2007133153A8 (en) | Improved antimicrobial peptides | |
| RU2010128247A (en) | SYNTHESIS OF INSULINOTROPIC PEPTIDES USING COMBINED SOLID-PHASE AND SOLUTION METHODS | |
| Kikuchi et al. | Solid phase total synthesis of callipeltin E isolated from marine sponge Latrunculia sp. | |
| CA2859708C (en) | Cyclotides as immunosuppressive agents | |
| EA201792362A8 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELIACIA SPRU | |
| Degenkolb et al. | Natural cyclopeptaibiotics and related cyclic tetrapeptides: structural diversity and future prospects | |
| WO2007139921A3 (en) | N-oxides of kappa opioid receptor peptides | |
| CL2022000016A1 (en) | Compounds comprising a fibroblast activation protein ligand and use thereof | |
| WO2008113536A8 (en) | Neurotrophic peptides | |
| EP4272751A3 (en) | Compstatin analogues and their medical uses | |
| McKinnie et al. | The solid phase supported peptide synthesis of analogues of the lantibiotic lactocin S | |
| IN2014DN08984A (en) | ||
| PH12021551055A1 (en) | Klk5 inhibitory peptide | |
| NZ755628A (en) | Engineered phenylalanine ammonia lyase polypeptides | |
| CA2508696C (en) | Process for the preparation of bicyclic peptide compounds | |
| Galpin et al. | Synthesis of cyclosporin analogues | |
| WO2009032181A3 (en) | Methods and intermediates for chemical synthesis of polypeptides and proteins | |
| WO2008114577A3 (en) | Antibacterial peptide | |
| AR102830A1 (en) | CYCLIC PEPTIDES DERIVED FROM POLYMIXIN AND ITS USE IN THE TREATMENT OF BACTERIAL INFECTIONS |